Home › Funds › Soleus Capital Management, L.P. › LEGN
Soleus Capital Management, L.P. position in LEGN
LEGEND BIOTECH CORP · Health Care
Soleus Capital Management, L.P. reported holding 1,085,550 shares of LEGN (LEGEND BIOTECH CORP) in its Q3 2026 13F filing — a position valued at US$21.6M, representing 0.77% of its reported portfolio and ranking #29 among its reported holdings. Soleus Capital Management, L.P. has disclosed LEGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s LEGN position evolved
Soleus Capital Management, L.P. first disclosed a stake in LEGN in Q2 2026 at 1,205,000 shares (US$34.8M). Across 2 filings, Soleus Capital Management, L.P. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,085,550 shares valued at US$21.6M — a reduction of -119,450 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.21M | $34.80M | New |
| Q3 2026 | 1.09M | $21.59M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LEGN and 13F data
LEGN (LEGEND BIOTECH CORP) is a Health Care company. 12 other funds we track also report a position in LEGN — the largest reported positions include Kynam Capital Management, LP (US$182.1M), Hillhouse Capital (HHLR Advisors) (US$166.3M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$161.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LEGN
- Kynam Capital Management, LP 9.15M sh · $182.08M · Q3 2026
- Hillhouse Capital (HHLR Advisors) 8.36M sh · $166.31M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 8.14M sh · $161.86M · Q3 2026
- MONTANOVA CAPITAL, LLC 6.23M sh · $123.91M · Q3 2026
- Elmind Capital, LP 1.57M sh · $31.22M · Q3 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held LEGN?
Soleus Capital Management, L.P. has disclosed LEGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Soleus Capital Management, L.P.'s current position in LEGN?
As of Q3 2026, Soleus Capital Management, L.P. holds 1.09M shares of LEGN (LEGEND BIOTECH CORP), valued at $21.59M, representing 0.77% of its reported portfolio and ranking #29.
Has Soleus Capital Management, L.P. been buying or selling LEGN?
In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. reduced its position in LEGN.
Which other funds hold LEGN?
Other major institutional holders of LEGN include Kynam Capital Management, LP, Hillhouse Capital (HHLR Advisors), DEERFIELD MANAGEMENT COMPANY, L.P., among 12 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.